# Cannabis Use, Cognition, and the Endocannabinoid System in HIV

> **NCT04883255** · EARLY_PHASE1 · RECRUITING · sponsor: **University of California, San Diego** · enrollment: 138 (estimated)

## Conditions studied

- HIV-1-infection

## Interventions

- **DRUG:** 10 mg Δ9-tetrahydrocannabinol (THC)
- **DRUG:** 600 mg cannabidiol (CBD)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04883255
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-03
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04883255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04883255, "Cannabis Use, Cognition, and the Endocannabinoid System in HIV". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04883255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*